12/01/2019 00:35:18

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in GreenSky, Inc. of Class Action Lawsuit and Upcoming Deadline – GSKY

NEW YORK, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against, GreenSky, Inc. (“GreenSky” or the “Company”) (NASDAQ: GSKY) and certain of its officers.  The class action, filed in United States District Court, Southern District of New York, and indexed under 19-cv-00100, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise, acquired GreenSky Class A common stock pursuant or traceable to the Company’s false and misleading registration statement and prospectus, who were damaged thereby, and who seek to pursue remedies under the Securities Act of 1933 (“Securities Act”).

If you are a shareholder who purchased GreenSky Class A common stock pursuant or traceable to the Company’s registration statement and prospectus, you have until January 28, 2019, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com.  To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

[Click here to join this class action]

GreenSky is a financial technology company in Atlanta, Georgia, and runs an online platform that allows creditors to process loan applications at the point of sale.  GreenSky’s platform is actively used by over 10,000 businesses. Consumers use GreenSky’s mobile app to make purchases from those listed business by applying for on-the-spot financing via the app.

GreenSky’s two principal sources of revenue are: (i) “transaction fees” the Company receives upfront when a consumer secures a loan through the GreenSky platform and makes a purchase; and (ii) recurring fees generated from banks over the lives of loans it facilitates. Transaction fees are critical to GreenSky’s business. For example, transaction fees accounted for 87% of the Company’s revenue in 2017. These transaction fees vary per the particular agreement between GreenSky and a merchant.

On April 27, 2018, GreenSky filed a registration statement. Then, on May 25, 2018, GreenSky filed a prospectus for its upcoming initial public offering (“IPO”). GreenSky’s registration statement and prospectus are referred to herein as the “Offering Documents.”

On May 29, 2018, GreenSky’s IPO closed and the Company sold 43.7 million shares of Class A common stock at $23.00 per share in its IPO, for gross proceeds of over $1 billion.

The complaint alleges that The Offering Documents were negligently prepared and, as a result, contained untrue statements of material facts or omitted to state other facts necessary to make the statements made not misleading, and were not prepared in accordance with the rules and regulations governing their preparation as the Offering Documents failed to disclose: (i) that GreenSky was transitioning away from the solar power market in favor of the elective healthcare market; (ii) foreseeable negative effects on GreenSky’s profits because of significant differences in transaction fees GreenSky charged to different classes of merchants; (iii) the primacy of the merchant mix as a driver of GreenSky’s transaction-fee revenue; (iv) the ongoing deterioration in GreenSky’s transaction-fee revenue, while touting GreenSky’s growth and financial performance; (v) the negative impacts of GreenSky’s changing merchant mix on EBITDA; (vi) the markedly lower transaction fees GreenSky charges to healthcare companies; and (vii) as a result of the foregoing, GreenSky’s Offering Documents were materially false and misleading at all relevant times.

On August 7, 2018, GreenSky issued a release announcing its financial results for the second quarter of 2018. The release indicated that the Company’s transaction-fee rate was approximately 53 basis points below the rate achieved in the second quarter of 2017.  In an earnings call, Defendant Zalik acknowledged that this rapid reduction was attributable to the transition away from solar panel merchants and toward elective healthcare companies.

On November 6, 2018, GreenSky lowered its full-year 2018 transaction volume guidance from between $5.1 and $5.3 billion to between $4.9 and $5.1 billion and lowered its full-year 2018 Adjusted EBITDA guidance from between $192 and $199 million to between $165 and $175 million.  GreenSky attributed the reduction to a general labor shortage and unfavorable shifts in its loan mix. 

Following these disclosures, GreenSky’s stock price closed at $9.28 per share, a decline of $13.72, or approximately 60%, from the IPO price of $23.00 per share.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:

Robert S. Willoughby

Pomerantz LLP

rswilloughby@pomlaw.com

888-476-6529 ext. 9980

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
19 Mar
I:SP500
Hejsa Lidt forårs opdatering. Langsigtet konjunkturmodel: Nederst kan I se den langsigtede konjunktu..
63
18 Mar
GOMX
SAS's emmision overtegnet så de regner med 15MUSD i provenu samlet - godt nyt for GOMSpace hvis de k..
14
14 Mar
BA
Elliot.Blot for info så har jeg cirka 14.000 timer på 737 serien og der er altid problemer når en ty..
14
19 Mar
VELO
  Studiet er et randomiseret fase 4 forsøg, hvor man sammenligner forlænget frigivelse Envarsus XR (..
12
14 Mar
DANSKE
Danske Bank er sværd at værdiansætte set i forhold til den situation som Danske Bank befinder sig i...
12
13 Mar
ZEAL
Der er nogle enkelt punkter som jeg har noteret mig under læsningen af Årsrapporten 2018 samt de sen..
12
09:12
ZEAL
Jeg skrev til IR vedr. lidt forskelligt, her er deres svar:  Bliver der afholdt en Capital Market D..
11
18 Mar
BAVA
For mig virker det ret underligt at udmelding fra FDA om ydereligere 3mdr mere behandlingstid bliver..
11
15 Mar
PNDORA
Det forhold, at Pandora på trods af negativ analyse fra Carnegie og udbetaling af udbytte har holdt ..
11
19 Mar
FING-B
Siden topformationen i 23 området har trenden krydset flere støttelinjer og er nu ved en mulig dobbe..
10

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Health Insurance, Conagra, Kraft Heinz, and Diplomat and Encourages Investors to Contact the Firm
2
PDAC welcomes Federal Budget 2019
3
PureCircle Launches Next Generation Stevia Leaf Sweeteners in Singapore
4
NanoString Technologies Announces Pricing of Public Offering of 4,500,000 Shares of Common Stock
5
Dermira Prices $130.0 Million Public Offering of Common Stock

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
20 March 2019 20:06:48
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190320.1 - EUROWEB1 - 2019-03-20 21:06:48 - 2019-03-20 20:06:48 - 1000 - Website: OKAY